Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viatrexx is a private integrative wellness and natural health products company founded in 1999 by Stephen Emond. The company develops and manufactures oral, topical, and injectable formulas marketed through practitioner-focused channels in Canada and the United States. Its portfolio is positioned around drainage and detox, repair and regeneration, inflammatory management, immune support, metabolism and oxygenation, and related functional wellness categories. Viatrexx also offers contract manufacturing and private-label services and states that it uses a proprietary EZ Heartbeat Manufacturing Process in GMP-compliant production. The business appears to operate as a commercial-stage wellness manufacturer rather than a traditional clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viatrexx.